See also this year's filing and all EDGAR filings for this company.
PDF Report 0001302573_2017_Oncomed_Pharmaceuticals_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001302573, Oncomed Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 189,583,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 4,471,000 |
| 3 | remainder_Assets | 1,428,000 |
| 4 | LiabilitiesCurrent | 55,853,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 162,657,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 18,896,383 |
| 9 | ResearchAndDevelopmentExpense | 131,834,522 |
| 10 | remainder_Expenses | 16,434 |
| 11 | remainder_Revenues | 25,127,655 |
| 12 | remainder_NetIncome | 271,163 |
| 13 | remainder_ComprehensiveNetIncome | 1,252,817 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 195,482,000 |
| 1 | Liabilities | 218,510,000 |
| 2 | Expenses | 150,747,339 |
| 3 | Revenues | 25,127,655 |
| 4 | StockholdersEquity | -23,028,000 |
| 5 | NetIncome | -125,348,521 |
| 6 | ComprehensiveNetIncome | -124,722,112 |
| 7 | BaseVar | 295,695,487 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.845 |
| 9 | EconomicCapitalRatio | 1.33 |
Edgar->Model Mapping
Feature Distribution
Change over Time
